Work

Olutasidenib as maintenance therapy after treatment response in acute myeloid leukemia with persistent IDH1 mutation

Year: 2026

Type: article

Source: Blood Neoplasia

DOI: 10.1016/j.bneo.2026.100226

Authors: Brian A. Jonas, Karen Seiter, Andrew H. Wei, Eunice S. Wang, Sophia Wang, Aaron D. Sheppard, Stéphane de Botton

Institutions: University of California Davis Medical Center, University of California, Davis, New York Medical College, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre, Roswell Park Comprehensive Cancer Center, Rigel (United States), Institut Gustave Roussy

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

OpenAlex ID: W7141741217

FWCI:

Cites: 15

Cited by:

Related to: 10